Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR5 | P35346 | 2/20 | 0.39 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.39 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.39 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.39 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.39 |
| ▸ | FGF1 | P05230 | 2/20 | 0.38 |
| ▸ | FGF2 | P09038 | 2/20 | 0.38 |
| ▸ | VEGFA | P15692 | 2/20 | 0.38 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.34 |
| ▸ | CDC25B | P30305 | 4/20 | 0.34 |
| ▸ | GJB2 | P29033 | 1/20 | 0.34 |
| ▸ | NT5E | P21589 | 1/20 | 0.34 |
| ▸ | TACR2 | P21452 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26349606 | 0.88 | SLC6A2 (0.46) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL14667229 | 0.87 | SSTR1 (0.44) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL26349603 | 0.87 | LMNA (0.41) | BCHESLC6A2PDPK1MTORNT5E | |
| SCHEMBL26349588 | 0.87 | LMNA (0.41) | BCHESLC6A2PDPK1MTORNT5E | |
| SCHEMBL26349591 | 0.87 | LMNA (0.41) | BCHESLC6A2PDPK1MTORNT5E | |
| SCHEMBL26349599 | 0.85 | PDPK1 (0.38) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL26349592 | 0.85 | PDPK1 (0.38) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL18328600 | 0.85 | FGF1 (0.43) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL15504369 | 0.85 | FGF1 (0.43) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL769799 | 0.84 | SSTR1 (0.47) | SSTR5SSTR1SSTR2SSTR4SSTR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303618-A1 | TRIPTOLIDE CONJUGATES AND USES THEREOF | REYOUNG CORPORATION (US) | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303618-A1 | TRIPTOLIDE CONJUGATES AND USES THEREOF | TLR9, XIAP, ENPP2 | SSTR5 2945/4885SSTR1 4385/4885SSTR2 3807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.